Evidence map›Paper›PMID 18385393›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2008

Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure.

Krista L Lentine, Lisa A Rocca Rey, Swathy Kolli, Giuliana Bacchi, Mark A Schnitzler, Kevin C Abbott, Huiling Xiao, Daniel C Brennan

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Management of antithrombotic therapies in kidney transplantation candidates and recipients: an ERBP clinical practice document by the DESCaRTES Working Group of ERA and the EKITA Committee of ESOT.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026
    Guideline
  2. Pooled it
  3. Generalizability of kidney transplant data in electronic health records - The Epic Cosmos database vs the Scientific Registry of Transplant Recipients.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. The Prevalence of Neurological Complication after Renal Transplantation.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  12. Article
  13. Evolving spectrum of diabetic nephropathy.World journal of diabetes · 2019
    Review
  14. Article
  15. Induction immunosuppression agents as risk factors for incident cardiovascular events and mortality after kidney transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Article
  16. Review
  17. Review
  18. Article
  19. The Risk of Stroke in Kidney Transplant Recipients with End-Stage Kidney Disease.International journal of environmental research and public health · 2019
    Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Krista L LentineSt. Louis University Center for Outcomes Research, Salus Center 2nd Floor, 3545 Lafayette Avenue, St. Louis, MO 63104, USA. lentine.krista@stanfordalumni.org.
Lisa A Rocca Rey
Swathy Kolli
Giuliana Bacchi
Mark A Schnitzler
Kevin C Abbott
Huiling Xiao
Daniel C Brennan
UCLouvain Saint-Louis Brussels · BEUniversity of Bologna · ITUniversity of Milan · ITWalter Reed Army Institute of Research · USWashington University in St. Louis · US

Funding

Washington University Center for Kidney Disease ResearchP30DK079333 · NIDDK · WASHINGTON UNIVERSITY · PI HAMMERMAN, MARC RANDALL · 2007 to 2011
$5.1M
Cardiovascular Risk Prediction after Kidney TransplantK08DK073036 · NIDDK · SAINT LOUIS UNIVERSITY · PI LENTINE, KRISTA L · 2006 to 2010
$668k
NIDDK NIH HHS K08 DK073036NIDDK NIH HHS K08DK073036NIDDK NIH HHS P30 DK079333
6 · The paper itself

Abstract

BACKGROUND AND

objectivesThis study examined the risks, predictors, and mortality implications of cerebrovascular disease events after kidney transplantation in a national cohort. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This analysis used United States Renal Data System registry data to study retrospectively Medicare-insured kidney transplant candidates (n = 51,504), recipients (n = 29,614), and recipients with allograft failure (n = 2954) in 1995 through 2002. New-onset cerebrovascular disease events including ischemic stroke, hemorrhagic stroke, and transient ischemic attacks were ascertained from billing records, and participants were followed until Medicare-end or December 31, 2002. Multivariable survival analysis was used to compare cerebrovascular disease event incidence and risk profiles among the study samples.

resultsThe cumulative, 3-yr incidence of de novo cerebrovascular disease events after transplantation was 6.8% and was lower than adjusted 3-yr estimates of 11.8% on the waiting list and 11.2% after graft loss. In time-dependent regression, transplantation predicted a 34% reduction in subsequent, overall cerebrovascular disease events risk compared with remaining on the waiting list, whereas risk for cerebrovascular disease events increased >150% after graft failure. Similar relationships with transplantation and graft loss were observed for each type of cerebrovascular disease event. Smoking was a potentially preventable correlate of posttransplantation cerebrovascular disease events. Women were not protected. All forms of cerebrovascular disease event diagnoses after transplantation predicted increased mortality.

conclusionsAlong with known benefits for cardiac complications, transplantation with sustained graft function seems to reduce risk for vascular disease events involving the cerebral circulation.

Indexed as

Waiting ListsAdolescentAdultBrain IschemiaCerebral HemorrhageCerebrovascular DisordersChildChild, PreschoolFemaleGraft RejectionHumansInfantInfant, NewbornIschemic Attack, TransientKidney TransplantationMale

Identifiers

PMID18385393
PMCPMC2440268
OpenAlexW2088737347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.